Re: news from ASCO-- some joyous, some a downer--may set things back a bit
Annette - we want you to live too!
I don't know if the 4% is correct, but am so pleased that you have both Perjeta and Kadcyla to use against stage IV Her2 cancer.
I will agree the system does not work efficiently and effectively for stage IV in desperate need of controlling their disease.
However, some still benefit from the recent progress - hoping it will be you in that category.
best regards,
|